Tag Archives: pharmaceutical

Hepatitis A Virus Cellular Receptor 2 – Pipeline Review: Share, Growth, Trends and Forecast

Market Research HUB

Albany, New York, June 16, 2017: Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) – “Hepatitis A virus cellular receptor” 2 (HAVCR2) is a protein encoded by the HAVCR2 gene. It inhibits T-helper type 1 lymphocyte (Th1)-mediated auto- and alloimmune responses and promotes immunological tolerance. Binding to LGALS9 is proposed to be involved in innate immune response to intracellular pathogens and suppression of T-cell responses the resulting apoptosis of antigen-specific cells implicate HAVCR2s phosphorylation and disruption of its association with BAG6.

Fibroblast Growth Factor Receptor 4- Pipeline Review : Size, Share, Growth, Trends and Forecast 2017 – 2022

Market Research HUB

Albany, New York, June 16, 2017:  “Fibroblast Growth Factor Receptor” 4 (CD334 or FGFR4 or EC 2.7.10.1) pipeline Target constitutes close to 24 molecules. Out of which approximately 23 molecules are developed by companies and remaining by the universities/institutes. The latest report Fibroblast Growth Factor Receptor 4 – Pipeline Review, H1 2017, outlays comprehensive information on the Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Request For Free Sample @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1157699

Global Immunology Drugs Market – Increasing Occurrence and Strong Acceptance of Interleukin Receptor Inhibitors to Drive Growth until 2022

Albany, New York, June 16, 2017: A report titled “Global Immunology Drugs Market 2017” has been recently added to the vast online repository of Market Research Hub (MRH). Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation. Depending on the specific site affected, this can lead to various types of chronic pain and mobility loss, and have a negative impact on quality of life.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1160848

Global Heart Rate Monitoring Devices Market Will Grow At A CAGR Of 13.12% During The Period 2017-2020

ResearchMoz presents professional and in-depth study of “Global Heart Rate Monitoring Devices Market 2016-2020”.

Diagnostic wearable medical devices, used for monitoring, controlling, and tracking an individual’s vital signs at regular intervals, have gained momentum in the past few years. These devices measure physiological information through remote or wireless communication and transmit this information to medical professionals or the user. These autonomous, non-invasive devices help assess specific medical functions such as body temperature, blood pressure, glucose quantity, respiratory rate, heart rate, and blood oxygen saturation.

Technavios analysts forecast the global heart rate monitoring device market to grow at a CAGR of 13.12% during the period 2016-2020.

Global Telemedicine Technologies and Services Market Expected to Reach US$ 86.7 Bn in 2023 – Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023

ResearchMoz added Latest Research Report titled ” Telemedicine Technologies and Services Market (Component – Hardware, Software, and Services; End-user – Telehospital and Telehome) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023 ” to it’s Large Report database.

Bladder Cancer Therapeutic and Drug Pipeline Review, H1 2017 complete with Analysis by stage of Development, Drug Target, MoA, RoA, and Molecule Type

ResearchMoz added Latest Research Report titled ” Bladder Cancer – Pipeline Review, H1 2017 ” to it’s Large Report database.

Bladder Cancer – Pipeline Review, H1 2017

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H1 2017, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, *** and color, certain parasitic infections. Treatment of bladder cancer includes chemotherapy, surgery, biological therapy and radiation therapy.

Analysis Of Current Scenario, Demographics, Epidemiological Study, Future Trends & Competition Of Viral Conjunctivitis Pipeline Drugs Market (FST-100 and APD-209) During 2020 – 2023

Researchmoz added Most up-to-date research on “Analysis Of Current Scenario, Demographics, Epidemiological Study, Future Trends &  Competition Of Viral Conjunctivitis Pipeline Drugs Market (FST-100 and APD-209) During 2020 – 2023” to its huge collection of research reports.

This report analyzes the current and future prospects of the viral conjunctivitis pipeline drugs market across major countries. Viral conjunctivitis is a highly contagious disease; however, not a single drug has been approved by the U.S. FDA to treat it. Hence, demand for these drugs for viral conjunctivitis is likely to increase after their expected launch.

Bacterial Conjunctivitis Drugs Market in U.S. to Reach US$439.8 Mn by 2024; Patent Expirations Could Adversely Impact Growth

ResearchMoz added Latest Research Report titled ” Bacterial Conjunctivitis Drugs Market – U.S. Industry Analysis, Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2012 – 2024 ” to it’s Large Report database.

Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in the commercialization of antibacterial drugs as well as new participants who wish to enter the U.S. market.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market Report analyzes and Researches the Industry Size, Status and Forecast 2022

ResearchMoz added Latest Research Report titled ” Global Hematopoietic Stem Cell Transplantation (HSCT) Market Size, Status and Forecast 2022 ” to it’s Large Report database.

This report studies the global Hematopoietic Stem Cell Transplantation (HSCT) market, analyzes and researches the Hematopoietic Stem Cell Transplantation (HSCT) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Regen Biopharma Inc
China Cord Blood Corp
CBR Systems Inc
Escape Therapeutics Inc
Cryo-Save AG
Lonza Group Ltd
Pluristem Therapeutics Inc
ViaCord Inc

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1102149

Designed by CyFocus.com
Powered by CyFocus.net